Desq Long
Sign in

Company

ORAMED PHARMACEUTICALS INC.

ORMP · CIK 0001176309

SEC FORM 4
—

ORAMED PHARMACEUTICALS INC. (ORMP)

Acquisition (code A) of 209,291 shares; price not stated (see filing).

Reporting Person Gabay Avraham · Officer Title Chief Financial Officer · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001213900-26-103535 · filed 2026-09-25 · View filing →

SEC FORM 4
—

ORAMED PHARMACEUTICALS INC. (ORMP)

Acquisition (code A) of 208,125 shares; price not stated (see filing).

Reporting Person Kidron Miriam · Officer Title Chief Scientific Officer · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001213900-26-103536 · filed 2026-09-25 · View filing →

SEC FORM 4
—

ORAMED PHARMACEUTICALS INC. (ORMP)

Acquisition (code A) of 209,291 shares; price not stated (see filing).

Reporting Person Kidron Miriam · Officer Title Chief Scientific Officer · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001213900-26-103536 · filed 2026-09-25 · View filing →

SEC FORM 4
—

ORAMED PHARMACEUTICALS INC. (ORMP)

Acquisition (code A) of 75,455 shares; price not stated (see filing).

Reporting Person Hexter Joshua · Officer Title COO & CBO · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001213900-26-103538 · filed 2026-09-25 · View filing →

SEC FORM 4
—

ORAMED PHARMACEUTICALS INC. (ORMP)

Acquisition (code A) of 209,291 shares; price not stated (see filing).

Reporting Person Hexter Joshua · Officer Title COO & CBO · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001213900-26-103538 · filed 2026-09-25 · View filing →

SEC FORM 4
—

ORAMED PHARMACEUTICALS INC. (ORMP)

Acquisition (code A) of 349,497 shares; price not stated (see filing).

Reporting Person KIDRON NADAV · Officer Title President and CEO · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001213900-26-103540 · filed 2026-09-25 · View filing →

SEC FORM 4
—

ORAMED PHARMACEUTICALS INC. (ORMP)

Acquisition (code A) of 368,765 shares; price not stated (see filing).

Reporting Person KIDRON NADAV · Officer Title President and CEO · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001213900-26-103540 · filed 2026-09-25 · View filing →